Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000120

President & Immunovant CEO sold 200,000 shares at $36.59 ($7,318,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2026-10-28 Sale 10b5-1 −200,000 $36.59 $7,318,000 1,199,154 D: show line 1 in the form
Open-market sales · 200,000 sh · avg $36.59 · $7,318,000
Loading xslF345X06/wk-form4_1793399338.xml…